Health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) treated with sotorasib and panitumumab (pmab) versus trifluridine/tipiracil (T/T) or regorafenib (rego) in CodeBreaK 300.
| Autor: | Modest, Dominik Paul, Fakih, Marwan, Salvatore, Lisa, Esaki, Taito, Paez Lopez-Bravo, David, Taieb, Julien, Karamouzis, Michalis, Ruiz-Garcia, Erika, Kim, Tae Won, Kuboki, Yasutoshi, Meriggi, Fausto, Cunningham, David, Yeh, Kun-Huei, Cremolini, Chiara, Tran, Qui, Chan, Emily, Chao, Joseph, Majer, Istvan Matyas, Pietrantonio, Filippo |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p10-10, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|